Session » Abstracts: RA – Diagnosis, Manifestations, & Outcomes III: Predicting & Optimizing Outcomes

Date: Tuesday, November 14, 2023

Time: 2:00PM-3:30PM

Meeting: ACR Convergence 2023

2:00PM-3:30PM: Abstract Number: 2483

CD68 and Fibrinoid Necrosis Are Synovial Biomarkers of Severity in Early Rheumatoid Arthritis and Are Associated with a Better Response to Methotrexate: Analysis of the UCLouvain Brussels ERA Cohort

2:00PM-3:30PM: Abstract Number: 2480

Definition of Rheumatoid Arthritis Flare Based on SDAI and CDAI

2:00PM-3:30PM: Abstract Number: 2484

Optimizing the Care of the Rheumatic Patient with Rheumatologist-Pharmacist Co-management

2:00PM-3:30PM: Abstract Number: 2481

Pre-pregnancy Gene Expression Signatures Among Women with Rheumatoid Arthritis May Represent Predictive Biomarkers for Subsequent Improvement or Worsening During Pregnancy

2:00PM-3:30PM: Abstract Number: 2482

Preinflammatory Mesenchymal (PRIME) Cell Signature Genes Enrichment Predicts Treatment Response and Joint Prognosis in Rheumatoid Arthritis

2:00PM-3:30PM: Abstract Number: 2479

Tolerability and Effectiveness of Antifibrotics in Rheumatoid Arthritis-associated Interstitial Lung Disease

« View all sessions from this meeting